Identification of HCN1 as a 14-3-3 client.

Area of Science:

• Neuroscience
• Molecular Biology
• Channelopathies

Background:

• Hyperpolarization activated cyclic nucleotide-gated channel 1 (HCN1) is crucial for neuronal excitability and its dysfunction is linked to epilepsy.
• HCN1 undergoes adaptive and pathogenic modulation, with phosphorylation identified as a key regulatory mechanism.
• 14-3-3 proteins are potential regulators of HCN1 function through phosphorylation-dependent interactions.

Purpose of the Study:

• To investigate the interaction between 14-3-3 proteins and HCN1.
• To identify the specific binding sites and mechanisms regulating HCN1 stability.
• To elucidate the role of this interaction in neuronal excitability and epilepsy.

Main Methods:

• Bioinformatic analysis to predict 14-3-3 binding sites on HCN1.
• Co-immunoprecipitation assays using various tissue sources and HEK293 cells to confirm HCN1-14-3-3 interaction.
• Site-directed mutagenesis to identify critical binding residues within HCN1.

Main Results:

• Three potential 14-3-3 binding sites were identified in HCN1 via bioinformatics.
• 14-3-3 proteins were shown to interact with HCN1 from multiple tissues and in HEK293 cells.
• Two sites in the intrinsically disordered C-terminus of HCN1 were necessary and sufficient for phosphorylation-dependent 14-3-3 binding.
• The same region is involved in phosphorylation-independent protein degradation of HCN1.

Conclusions:

• Phosphorylation of HCN1 at specific C-terminal sites (mouse S810/S867, human S789/S846) recruits 14-3-3 proteins.
• This recruitment likely inhibits a degradation pathway, increasing HCN1 half-life.
• The findings provide a novel mechanism for regulating HCN1 stability and offer potential therapeutic targets for epilepsy.